Nanoparticle encapsulation of mitaplatin and the effect thereof on in vivo properties
about
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) ProdrugsPolymeric Nanostructures for Imaging and TherapyTargeted nanoparticles for image-guided treatment of triple-negative breast cancer: clinical significance and technological advancesTumour-associated macrophages act as a slow-release reservoir of nano-therapeutic Pt(IV) pro-drug.Triple Negative Breast Cancer: Nanosolutions for a Big Challenge.A multi-functional PEGylated gold(iii) compound: potent anti-cancer properties and self-assembly into nanostructures for drug co-deliveryEnhanced and Extended Anti-Hypertensive Effect of VP5 Nanoparticles.Overcoming tumor resistance to cisplatin through micelle-mediated combination chemotherapy.Imaging the pharmacology of nanomaterials by intravital microscopy: Toward understanding their biological behavior.An Iron Oxide Nanocarrier Loaded with a Pt(IV) Prodrug and Immunostimulatory dsRNA for Combining Complementary Cancer Killing Effects.Therapeutic applications of dichloroacetate and the role of glutathione transferase zeta-1.Platinum compounds for high-resolution in vivo cancer imaging.Core-shell polymer nanoparticles for prevention of GSH drug detoxification and cisplatin delivery to breast cancer cells.Influence of the Number of Axial Bexarotene Ligands on the Cytotoxicity of Pt(IV) Analogs of Oxaliplatin.Liver-targeted cyclosporine A-encapsulated poly (lactic-co-glycolic) acid nanoparticles inhibit hepatitis C virus replication.Nanomedicine for the treatment of triple-negative breast cancer.αvβ3 integrin-targeted micellar mertansine prodrug effectively inhibits triple-negative breast cancer in vivo.Therapeutic Targeting of the Pyruvate Dehydrogenase Complex/Pyruvate Dehydrogenase Kinase (PDC/PDK) Axis in Cancer.Modified nanoprecipitation method for polysulfone nanoparticles preparation.Pros and cons of bifunctional platinum(iv) antitumor prodrugs: two are (not always) better than one
P2860
Q28066801-6818A356-7B7D-4FA9-ACB1-13DC0F10CF40Q30372383-9E45E11A-2B7C-41B7-8A59-3D414DD0EF89Q36157045-2AFEB0F9-DDFE-44A0-8304-F7A4BDFD904BQ36459188-33ED93EB-87F7-489F-9019-0DA6F874BDC4Q37422972-6B5720E9-D461-41B5-AA21-A89001FD1816Q38705760-EDBA9B00-DF2F-44BF-BF19-647E71D15F42Q38789463-A1B41BAE-CBFA-47AF-A9EF-F79DBF97F47DQ38848959-9DEBAA3F-08FD-4E09-B463-9612A499F526Q38856246-22B1E7DB-CFA5-490E-A3B9-CAEC6889BB03Q38890431-9253A780-9B5E-4A90-B2DB-C252452A3BDFQ38988403-15C2CCAC-83EC-4FA1-9621-344FA3C76F86Q39026285-27E5DA3F-084D-47A6-91E8-74D4D877C42EQ40433843-3D9B50AE-3AF3-4D20-812B-57638AC8A7A7Q41212195-EE9F2777-450E-44FD-BF85-5C9253ADF68AQ41488466-A618383C-9283-470C-988F-F73B61702EF4Q45758946-5F428436-2056-45DD-8472-299607562E7EQ47097144-1C9AFD60-6859-4DEB-BDAF-53C1A832A7B4Q47615969-590353E2-4617-4B5B-AB05-9F5487FA6E3BQ53595449-3BA42ED5-7088-4F88-A2D2-89E0C9433474Q59229081-C8315DAF-067F-46E5-A185-7D8A321EB9C8
P2860
Nanoparticle encapsulation of mitaplatin and the effect thereof on in vivo properties
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 May 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Nanoparticle encapsulation of mitaplatin and the effect thereof on in vivo properties
@en
Nanoparticle encapsulation of mitaplatin and the effect thereof on in vivo properties.
@nl
type
label
Nanoparticle encapsulation of mitaplatin and the effect thereof on in vivo properties
@en
Nanoparticle encapsulation of mitaplatin and the effect thereof on in vivo properties.
@nl
prefLabel
Nanoparticle encapsulation of mitaplatin and the effect thereof on in vivo properties
@en
Nanoparticle encapsulation of mitaplatin and the effect thereof on in vivo properties.
@nl
P2093
P2860
P50
P356
P1433
P1476
Nanoparticle encapsulation of mitaplatin and the effect thereof on in vivo properties
@en
P2093
Eric M Pridgen
Robert Langer
Stephen J Lippard
P2860
P304
P356
10.1021/NN401905G
P407
P577
2013-05-22T00:00:00Z